Ipratropium Bromide (Atrovent)
⚠️ Ipratropium bromide can cause eye complications if aerosol/nebuliser mist reaches the eyes.
➡️ Contact with the eye may cause a unilateral dilated pupil, eye pain, and can precipitate acute angle-closure glaucoma.
📖 About
Always check the BNF link here for full details.
- 💨 Short-acting inhaled anticholinergic bronchodilator (SAMA).
- Used in both Asthma and COPD management, especially acute settings.
⚙️ Mechanism of Action
- Blocks muscarinic (M3) receptors in airway smooth muscle → bronchodilation.
- Onset: 30–60 minutes ⏱️.
- Duration: 3–6 hours → typically dosed every 6–8 hours.
🎯 Indications & Dosing
- 🫁 Chronic Asthma/COPD:
Ipratropium aerosol 20–40 mcg every 6 hours (max 80 mcg q6h).
Onset 30–60 min, lasts ~6 hours.
- 🚨 Acute Asthma / COPD Exacerbation:
Ipratropium Bromide (Atrovent) Nebulised 250–500 mcg every 4–6 hours.
⚠️ Use with air in COPD (to avoid CO₂ retention).
⚠️ Use with high-flow oxygen in acute asthma.
⛔ Cautions / Contraindications
- Glaucoma (risk of precipitating acute angle closure 👁️).
- Prostatic hypertrophy / urinary retention risk 💧.
- Care in patients with bladder outflow obstruction or arrhythmias.
⚠️ Side Effects
- Blurred vision, dilated pupils, eye pain 👁️.
- Dry mouth, throat irritation, urinary retention.
- Flushing, tachycardia, palpitations ❤️.
- Headache, constipation.
- Allergic reactions (skin rash, angioedema).
- Rare: paradoxical bronchospasm 🚫.
📚 References